Financial Summary (All financials)
In millions of CNY, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
Revenues | 4,657.0 | 2,580.8 | 2,473.1 |
Revenue growth | 80.4% | 4.4% | |
Cost of goods sold | 2,540.0 | 1,316.0 | 1,389.9 |
Gross profit | 2,117.0 | 1,264.8 | 1,083.2 |
Gross margin | 45.5% | 49.0% | 43.8% |
Sales and marketing | 837.3 | 454.3 | 403.1 |
Research and development | 729.7 | 413.4 | 396.7 |
General and administrative | 4,271.2 | 3,938.6 | 1,189.4 |
EBITA | -3,645.7 | -3,556.6 | -267.5 |
EBITA margin | -78.3% | -137.8% | -10.8% |
Amortization of intangibles | 50.0 | 47.0 | 44.5 |
EBIT | -3,695.7 | -3,603.6 | -312.0 |
EBIT margin | -79.4% | -139.6% | -12.6% |
Pre-tax income | -3,640.3 | -3,451.6 | -1,556.3 |
Income taxes | 14.2 | 19.3 | -14.7 |
Tax rate | | | 0.9% |
Earnings from continuing ops | -4,172.9 | -3,591.0 | -1,541.7 |
Earnings from discontinued ops | | 0.5 | 18.0 |
Net income | -4,172.9 | -3,590.6 | -1,523.7 |
Net margin | -89.6% | -139.1% | -61.6% |
|
Diluted EPS | ($0.31) | ($1.05) | ($0.47) |
Shares outstanding (diluted) | 13,446.0 | 3,423.7 | 3,299.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|